| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.34▲ | 10.30▲ | 10.33▲ | 10.45▼ | 10.11▲ |
| MA10 | 10.31▲ | 10.28▲ | 10.26▲ | 10.29▲ | 10.57▼ |
| MA20 | 10.31▲ | 10.22▲ | 10.40▼ | 9.92▲ | 13.37▼ |
| MA50 | 10.26▲ | 10.57▼ | 10.40▼ | 10.59▼ | 16.22▼ |
| MA100 | 10.60▼ | 10.25▲ | 9.95▲ | 14.04▼ | N/A |
| MA200 | 10.37▲ | 9.84▲ | 10.10▲ | 16.43▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.010▲ | 0.039▲ | 0.005▲ | 0.163▲ | -0.081▼ |
| RSI | 53.758▲ | 51.832▲ | 49.372▼ | 49.990▼ | 39.583▼ |
| STOCH | 79.885 | 72.954 | 79.468 | 61.356 | 29.870 |
| WILL %R | -3.448▲ | -3.448▲ | -2.667▲ | -40.441 | -76.951▼ |
| CCI | 70.823 | 99.187 | 119.501▲ | 31.082 | -53.008 |
|
Friday, May 30, 2025 04:11 AM
Cartesian Therapeutics, Inc. has announced the enrollment of the first participant in its Phase 3 AURORA trial for Descartes-08, its lead cell therapy candidate aimed at treating myasthenia gravis ...
|
|
Sunday, May 11, 2025 01:56 AM
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) investors will be delighted, with the company turning in some strong numbers with its latest results. Overall results were decent, with revenues of US$1 ...
|
|
Thursday, May 08, 2025 04:14 AM
May 08, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/06/25 | 10.10 | 10.38 | 10.10 | 10.38 | 7,724 |
| 13/06/25 | 10.02 | 10.44 | 10.015 | 10.42 | 45,405 |
| 12/06/25 | 10.27 | 10.315 | 9.90 | 10.24 | 41,609 |
| 11/06/25 | 11.04 | 11.26 | 10.41 | 10.41 | 44,085 |
| 10/06/25 | 10.635 | 11.37 | 10.635 | 10.795 | 46,406 |
| 09/06/25 | 11.43 | 11.48 | 10.50 | 10.85 | 65,878 |
| 06/06/25 | 9.42 | 11.12 | 9.18 | 11.035 | 100,184 |
| 05/06/25 | 9.55 | 9.55 | 9.01 | 9.34 | 82,566 |
| 04/06/25 | 9.90 | 10.01 | 9.365 | 9.54 | 70,079 |
| 03/06/25 | 9.98 | 10.12 | 9.80 | 9.90 | 36,274 |
|
|
||||
|
|
||||
|
|